(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
0.00% $ 381.02
Live Chart Being Loaded With Signals
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients...
Stats | |
---|---|
Dzisiejszy wolumen | 15.70M |
Średni wolumen | 1.70M |
Kapitalizacja rynkowa | 17.18B |
EPS | $2.34 ( Q2 | 2022-11-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
65.36 (Sector) 42.63 (Industry) 43.86 |
ATR14 | $4.67 (1.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-22 | Sutter Martin P | Sell | 123 370 | Common Stock, $0.01 par value |
2022-12-22 | Puhy Dorothy E | Sell | 11 335 | Common Stock, $0.01 par value |
2022-12-22 | Trapp Todd A | Buy | 26 023 | Performance Stock Units |
2022-12-22 | Trapp Todd A | Sell | 26 023 | Performance Stock Units |
2022-12-22 | Plano Matthew T. | Buy | 12 490 | Performance Stock Units |
INSIDER POWER |
---|
-27.53 |
Last 100 transactions |
Buy: 215 643 | Sell: 404 694 |
Wolumen Korelacja
Abiomed, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Abiomed, Inc. Korelacja - Waluta/Towar
Abiomed, Inc. Finanse
Annual | 2022 |
Przychody: | $1.03B |
Zysk brutto: | $843.60M (81.76 %) |
EPS: | $3.00 |
FY | 2022 |
Przychody: | $1.03B |
Zysk brutto: | $843.60M (81.76 %) |
EPS: | $3.00 |
FY | 2021 |
Przychody: | $847.52M |
Zysk brutto: | $685.62M (80.90 %) |
EPS: | $5.00 |
FY | 2020 |
Przychody: | $840.88M |
Zysk brutto: | $689.58M (82.01 %) |
EPS: | $4.49 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Abiomed, Inc.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej